Sharps Technology, Inc. (NASDAQ:STSS – Get Free Report) was the target of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 40,800 shares, a drop of 32.0% from the November 15th total of 60,000 shares. Based on an average daily volume of 185,800 shares, the short-interest ratio is presently 0.2 days. Currently, 2.3% of the company’s shares are short sold.
Sharps Technology Trading Up 2.5 %
Shares of STSS traded up $0.05 during trading hours on Friday, reaching $2.04. 101,624 shares of the company traded hands, compared to its average volume of 209,400. The stock has a fifty day moving average of $2.83. The stock has a market capitalization of $3.67 million, a price-to-earnings ratio of -0.25 and a beta of 1.37. Sharps Technology has a 12-month low of $1.70 and a 12-month high of $18.15.
Institutional Investors Weigh In On Sharps Technology
An institutional investor recently bought a new position in Sharps Technology stock. Garden State Investment Advisory Services LLC purchased a new stake in shares of Sharps Technology, Inc. (NASDAQ:STSS – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned approximately 9.61% of Sharps Technology as of its most recent filing with the Securities & Exchange Commission. 17.17% of the stock is owned by institutional investors and hedge funds.
Sharps Technology Company Profile
Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.
Featured Stories
- Five stocks we like better than Sharps Technology
- Which Wall Street Analysts are the Most Accurate?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is MarketRankā¢? How to Use it
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Use Stock Screeners to Find Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Sharps Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Technology and related companies with MarketBeat.com's FREE daily email newsletter.